NKG2C, HLA-E and their association with psoriasis

Experimental Dermatology

Volumn 22, Issue 12, 2013, Pages 797-799

  Patel, Forum ^a   Marusina, Alina I ^a   Duong, Christopher ^a   Adamopoulos, Iannis E ^a   Maverakis, Emanual ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

0602; Antigen processing; HLA Cw; HLA E; Natural killer cells; NK T cells; NKG2A; NKG2C; Psoriasis

Indexed keywords

AUTOANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D;

ANTIGEN PRESENTATION; DISEASE ASSOCIATION; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NATURAL KILLER T CELL; NOTE; PATHOPHYSIOLOGY; PSORIASIS; SKIN DISEASE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGEN PROCESSING; HLA-CW*0602; HLA-E; NATURAL KILLER CELLS; NK T CELLS; NKG2A; NKG2C; PSORIASIS;

AUTOANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PEPTIDES; PROTEIN BINDING; PSORIASIS; T-LYMPHOCYTES;

EID: 84888362914     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12280     Document Type: Note

References (25)

1. Foley B, Cooley S, Verneris M R et al. Blood 2012: 119: 2665-2674.
2. Vivier E, Tomasello E, Baratin M et al. Nat Immunol 2008: 9: 503-510.
3. Walzer T, Dalod M, Robbins S H et al. Blood 2005: 106: 2252-2258.
4. Moretta L, Ferlazzo G, Bottino C et al. Immunol Rev 2006: 214: 219-228.
5. Degli-Esposti M A, Smyth M J. Nat Rev Immunol 2005: 5: 112-124.
6. Long E O, Kim H S, Liu D et al. Annu Rev Immunol 2013: 31: 227-258.
7. Orange J S. Nat Rev Immunol 2008: 8: 713-725.
8. Lang P A, Lang K S, Xu H C et al. Proc Natl Acad Sci U S A 2012: 109: 1210-1215.
9. Andrews D M, Estcourt M J, Andoniou C E et al. J Exp Med 2010: 207: 1333-1343.
10. Waggoner S N, Cornberg M, Selin L K et al. Nature 2012: 481: 394-398.
11. Ottaviani C, Nasorri F, Bedini C et al. Eur J Immunol 2006: 36: 118-128.
12. Sivamani R K, Goodarzi H, Garcia M S et al. Clin Rev Allergy Immunol 2013: 44: 121-140.
13. Bryceson Y T, March M E, Ljunggren H G et al. Immunol Rev 2006: 214: 73-91.
14. Lanier L L. Nat Immunol 2008: 9: 495-502.
15. Luszczek W, Manczak M, Cislo M et al. Hum Immunol 2004: 65: 758-766.
16. Holm S J, Sakuraba K, Mallbris L et al. J Invest Dermatol 2005: 125: 721-730.
17. Zeng X, Chen H, Gupta R et al. Exp Dermatol 2013: 22: 679-681.
18. Braud V M, Allan D S, O'Callaghan C A et al. Nature 1998: 391: 795-799.
19. Vance R E, Kraft J R, Altman J D et al. J Exp Med 1998: 188: 1841-1848.
20. Bland F A, Lemberg M K, McMichael A J et al. J Biol Chem 2003: 278: 33747-33752.
21. Park C O, Noh S, Jin S et al. Exp Dermatol 2013: 22: 6-9.
22. Balato A, Zhao Y, Harberts E et al. Exp Dermatol 2012: 21: 915-920.
23. Batista M D, Ho E L, Kuebler P J et al. Exp Dermatol 2013: 22: 64-66.
24. Pietra G, Romagnani C, Manzini C et al. J Biomed Biotechnol 2010: 2010: 907092.
25. Sercarz E E, Maverakis E. Nat Rev Immunol 2003: 3: 621-629.